{
  "doc_id": "doc2_1",
  "file_path": "/Users/maverick/Documents/Anusha/Unstructured/agentic/POC1/data/input/raw_documents/doc2_1.pdf",
  "total_pages": 5,
  "pages": [
    {
      "page_num": 1,
      "text": "Patient\nName: Alison Jones\nDate of Birth: 1941-07-04\nSex: Male\nCase Number: 4751\nDiagnosis: Lobular carcinoma in situ (LCIS)\nSpecimen Information\nPrimary Tumor Site: Breast\nSpecimen Site: Lymph nodes (axillary Specimen ID: 3372\nSpecimen Collected: 2024-03-30\nTest Initiated: 2024-03-31\nBiomarker\nMethod\nAnalyte\nResult\nTherapy association\nBiomarker level\nER\nIHC\nprotein\nPositive 3+, 100%\nBENEFIT\nabemaciclib, palbociclib, ribociclib, endocrine, therapy, everolimus\nlevel 2\nPR TMB  ERBB2\nIHC seq  IHC\nprotein DNA tumor  Protien\nPositive | 2+, 95% 11 m/Mb Low  Negative | 0\nBENEFIT BENEFIT LACK OF BENEFT\nabemaciclib, palbociclib, ribociclib, endocrine therapy pembrolizumab trastuzumab, ado-trastuzumab emtansine, pertuzumab, fam-trastuzumab deruxtecan-nxki, lapatinib, neratinib, tucatinib\nlevel 2 level 2  level 1\nFinal Report\nOrdered By\nPATIENT: Alison Jones\nCASE NUMBER: 4751\nPHYSICIAN: Dr. Wanda Nguyen\n",
      "paragraphs": [
        "Patient",
        "Name: Alison Jones",
        "Date of Birth: 1941-07-04",
        "Sex: Male",
        "Case Number: 4751",
        "Diagnosis: Lobular carcinoma in situ (LCIS)",
        "Specimen Information",
        "Primary Tumor Site: Breast",
        "Specimen Site: Lymph nodes (axillary Specimen ID: 3372",
        "Specimen Collected: 2024-03-30",
        "Test Initiated: 2024-03-31",
        "Biomarker",
        "Method",
        "Analyte",
        "Result",
        "Therapy association",
        "Biomarker level",
        "ER",
        "IHC",
        "protein",
        "Positive 3+, 100%",
        "BENEFIT",
        "abemaciclib, palbociclib, ribociclib, endocrine, therapy, everolimus",
        "level 2",
        "PR TMB  ERBB2",
        "IHC seq  IHC",
        "protein DNA tumor  Protien",
        "Positive | 2+, 95% 11 m/Mb Low  Negative | 0",
        "BENEFIT BENEFIT LACK OF BENEFT",
        "abemaciclib, palbociclib, ribociclib, endocrine therapy pembrolizumab trastuzumab, ado-trastuzumab emtansine, pertuzumab, fam-trastuzumab deruxtecan-nxki, lapatinib, neratinib, tucatinib",
        "level 2 level 2  level 1",
        "Final Report",
        "Ordered By",
        "PATIENT: Alison Jones",
        "CASE NUMBER: 4751",
        "PHYSICIAN: Dr. Wanda Nguyen"
      ],
      "layout_metadata": {
        "block_types": [
          "heading-1",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "heading-1",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "header",
          "paragraph",
          "footer",
          "footer",
          "footer"
        ],
        "has_tables": true
      }
    },
    {
      "page_num": 2,
      "text": "Cancer-Type Relevant Biomarkers\nBioMarker\nMethod\nAnalyte\nResult\nCHD6\nSeq\nRNA-Tumor\nStable\nPD-L1(SP142)\nIHC\nProtien\nPositive 1+, 29%\nCSF3R\nSeq\nRNA-Tumor\nStable\nPD-L1(SP142)\nIHC\nProtien\nPositive 3+, 6%\nPR\nIHC\nProtien\nPositive 1+, 7%\nBioMarker\nMethod\nAnalyte\nResult\nMismatch repair status\nIHC\nProtien\nNegative 3+, 49%\nPR\nIHC\nProtien\nNegative 2+, 21%\nPIK3CA\nSeq\nDNA-Tumor\nStable\nER\nIHC\nProtien\nNegative 3+, 62%\nMismatch repair status\nIHC\nProtien\nPositive 2+, 89%\nFinal Report\nGenomic Signatures\nBioMarker\nMethod\nAnalyte\nResult\nMicrosatellite instability\nSeq\nDNA tumor\nHigh\nTumor mutational burden\nSeq\nDNA tumor\n11 mutations/Mb Low\nGenomic loss of heterozygosity (LOH)\nSeq\nDNA tumor\nHigh - 34% of tested genmoic segments exhibit LOH\nGenes Tested with Pathogenic Alterations or likely Pathogenic Alterations\nGene\nMethod\nAnalyte\nVariant Interpretation\nProtien Alteration\nExon\nDNA Alteration\nAllele Frequency %\nDPYD\nSeq\nDNA tumor\nPathogenic\np.A374E\n7\n>\n27.28\nPIK3CA\nSeq\nDNA tumor\nPathogenic\np.N159Y\n14\n3\n11.28\nCD74\nSeq\nDNA tumor\nPathogenic\np.C481X\n11\n1\n21.45\nPDGFRB\nSeq\nDNA tumor\nPathogenic\np.G12D\n14\nc.35_36inv\n1.29\nPATIENT: Alison Jones\nCASE NUMBER: 4751\nPHYSICIAN: Dr. Wanda Nguyen\n",
      "paragraphs": [
        "Cancer-Type Relevant Biomarkers",
        "BioMarker",
        "Method",
        "Analyte",
        "Result",
        "CHD6",
        "Seq",
        "RNA-Tumor",
        "Stable",
        "PD-L1(SP142)",
        "IHC",
        "Protien",
        "Positive 1+, 29%",
        "CSF3R",
        "Seq",
        "RNA-Tumor",
        "Stable",
        "PD-L1(SP142)",
        "IHC",
        "Protien",
        "Positive 3+, 6%",
        "PR",
        "IHC",
        "Protien",
        "Positive 1+, 7%",
        "BioMarker",
        "Method",
        "Analyte",
        "Result",
        "Mismatch repair status",
        "IHC",
        "Protien",
        "Negative 3+, 49%",
        "PR",
        "IHC",
        "Protien",
        "Negative 2+, 21%",
        "PIK3CA",
        "Seq",
        "DNA-Tumor",
        "Stable",
        "ER",
        "IHC",
        "Protien",
        "Negative 3+, 62%",
        "Mismatch repair status",
        "IHC",
        "Protien",
        "Positive 2+, 89%",
        "Final Report",
        "Genomic Signatures",
        "BioMarker",
        "Method",
        "Analyte",
        "Result",
        "Microsatellite instability",
        "Seq",
        "DNA tumor",
        "High",
        "Tumor mutational burden",
        "Seq",
        "DNA tumor",
        "11 mutations/Mb Low",
        "Genomic loss of heterozygosity (LOH)",
        "Seq",
        "DNA tumor",
        "High - 34% of tested genmoic segments exhibit LOH",
        "Genes Tested with Pathogenic Alterations or likely Pathogenic Alterations",
        "Gene",
        "Method",
        "Analyte",
        "Variant Interpretation",
        "Protien Alteration",
        "Exon",
        "DNA Alteration",
        "Allele Frequency %",
        "DPYD",
        "Seq",
        "DNA tumor",
        "Pathogenic",
        "p.A374E",
        "7",
        ">",
        "27.28",
        "PIK3CA",
        "Seq",
        "DNA tumor",
        "Pathogenic",
        "p.N159Y",
        "14",
        "3",
        "11.28",
        "CD74",
        "Seq",
        "DNA tumor",
        "Pathogenic",
        "p.C481X",
        "11",
        "1",
        "21.45",
        "PDGFRB",
        "Seq",
        "DNA tumor",
        "Pathogenic",
        "p.G12D",
        "14",
        "c.35_36inv",
        "1.29",
        "PATIENT: Alison Jones",
        "CASE NUMBER: 4751",
        "PHYSICIAN: Dr. Wanda Nguyen"
      ],
      "layout_metadata": {
        "block_types": [
          "heading-2",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "header",
          "heading-1",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "heading-1",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "footer",
          "footer",
          "footer"
        ],
        "has_tables": true
      }
    },
    {
      "page_num": 3,
      "text": "Gene Variants of Unknown Significance\nFinal Report\nGene\nMethod\nAnalyte\nVariant Interpretation\nProtien Alteration\nExon\nDNA Alteration\nAllele Frequency %\nCALR\nSeq\nDNA tumor\nVariant of uncertain significance\np.N515H\n14\nA\n8.82\nSDHB\nSeq\nDNA tumor\nVariant of uncertain significance\np.L122R\n5\nc.365T>G\n24.79\nJAK3\nSeq\nDNA tumor\nVariant of uncertain significance\np.P904L\n16\nc.2711C>T\n1.11\nZEB2\nSeq\nDNA tumor\nVariant of uncertain significance\np.K8601\n19\nc.2238_2252del15\n2.88\nCDC73\nSeq\nDNA tumor\nVariant of uncertain significance\np.W266*\n3\nc.798G>A\n2.08\nImmunohistochemistry Results\nBiomarker\nResult\nAR\nNegative 2+, 4%\nPTEN\nNegative 1+, 74%\nPR\nPositive 3+, 85%\nMSH2\nPositive 3+, 69%\nMLH1\nNegative 1+, 7%\nBiomarker\nResult\nERBB2\nNegative 2+, 12%\nPMS2\nPositive 1+, 40%\nGenes Tested with Indeterminate Results by Tumor DNA Sequencing\nJAK2\nDICER1 PIK3CA SDHD\nPATIENT: Alison Jones\nCASE NUMBER: 4751\nPHYSICIAN: Dr. Wanda Nguyen\n",
      "paragraphs": [
        "Gene Variants of Unknown Significance",
        "Final Report",
        "Gene",
        "Method",
        "Analyte",
        "Variant Interpretation",
        "Protien Alteration",
        "Exon",
        "DNA Alteration",
        "Allele Frequency %",
        "CALR",
        "Seq",
        "DNA tumor",
        "Variant of uncertain significance",
        "p.N515H",
        "14",
        "A",
        "8.82",
        "SDHB",
        "Seq",
        "DNA tumor",
        "Variant of uncertain significance",
        "p.L122R",
        "5",
        "c.365T>G",
        "24.79",
        "JAK3",
        "Seq",
        "DNA tumor",
        "Variant of uncertain significance",
        "p.P904L",
        "16",
        "c.2711C>T",
        "1.11",
        "ZEB2",
        "Seq",
        "DNA tumor",
        "Variant of uncertain significance",
        "p.K8601",
        "19",
        "c.2238_2252del15",
        "2.88",
        "CDC73",
        "Seq",
        "DNA tumor",
        "Variant of uncertain significance",
        "p.W266*",
        "3",
        "c.798G>A",
        "2.08",
        "Immunohistochemistry Results",
        "Biomarker",
        "Result",
        "AR",
        "Negative 2+, 4%",
        "PTEN",
        "Negative 1+, 74%",
        "PR",
        "Positive 3+, 85%",
        "MSH2",
        "Positive 3+, 69%",
        "MLH1",
        "Negative 1+, 7%",
        "Biomarker",
        "Result",
        "ERBB2",
        "Negative 2+, 12%",
        "PMS2",
        "Positive 1+, 40%",
        "Genes Tested with Indeterminate Results by Tumor DNA Sequencing",
        "JAK2",
        "DICER1 PIK3CA SDHD",
        "PATIENT: Alison Jones",
        "CASE NUMBER: 4751",
        "PHYSICIAN: Dr. Wanda Nguyen"
      ],
      "layout_metadata": {
        "block_types": [
          "heading-1",
          "header",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "heading-1",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "heading-1",
          "paragraph",
          "paragraph",
          "footer",
          "footer",
          "footer"
        ],
        "has_tables": true
      }
    },
    {
      "page_num": 4,
      "text": "Final Report\nSpecimen Information\nSpecimen ID: 3372\nSpecimen Recieved: 2024-03-31 Gross Description: 3372\nPathological Diagnosis:\nSpecimen Collected: 2024-03-30 Testing Initiated: 2024-03-31\nLeft breast, central, 12:00, suspicious mass, 12-gauge core needle biopsy: Infiltrating moderately-differentiated mammary carcinoma, grade 2, Nottingham score 6 (architectural grade 3, nuclear grade 2, mitotic figures 1).\nDissection Information:\nMolecular testing of this specimen was performed after harvesting of targeted tissues with an approved manual microdissection technique. Candidate slides were examined under a microscope and areas containing tumor cells (and separately normal cells, when necessary for testing) were circled. A laboratory technician harvested targeted tissues for extraction from the marked areas using a dissection microscope.\nPATIENT: Alison Jones\nCASE NUMBER: 4751\nPHYSICIAN: Dr. Wanda Nguyen\n",
      "paragraphs": [
        "Final Report",
        "Specimen Information",
        "Specimen ID: 3372",
        "Specimen Recieved: 2024-03-31 Gross Description: 3372",
        "Pathological Diagnosis:",
        "Specimen Collected: 2024-03-30 Testing Initiated: 2024-03-31",
        "Left breast, central, 12:00, suspicious mass, 12-gauge core needle biopsy: Infiltrating moderately-differentiated mammary carcinoma, grade 2, Nottingham score 6 (architectural grade 3, nuclear grade 2, mitotic figures 1).",
        "Dissection Information:",
        "Molecular testing of this specimen was performed after harvesting of targeted tissues with an approved manual microdissection technique. Candidate slides were examined under a microscope and areas containing tumor cells (and separately normal cells, when necessary for testing) were circled. A laboratory technician harvested targeted tissues for extraction from the marked areas using a dissection microscope.",
        "PATIENT: Alison Jones",
        "CASE NUMBER: 4751",
        "PHYSICIAN: Dr. Wanda Nguyen"
      ],
      "layout_metadata": {
        "block_types": [
          "header",
          "heading-1",
          "paragraph",
          "paragraph",
          "heading-2",
          "paragraph",
          "paragraph",
          "heading-2",
          "paragraph",
          "footer",
          "footer",
          "footer"
        ],
        "has_tables": false
      }
    },
    {
      "page_num": 5,
      "text": "Clinical Trials Connector\nFinal Report\nCHEMOTHERAPY CLINICAL TRIALS\nDrug class\nBiomarker |\nMethod\nAnalyte\nInvestigational agents\nAnti hormonal therapy\nER\nIHC\nprotein\nanastrazole, letrozole, exemestane, fulvestrant, tamoxifen, goserelin, leuprolide\nAnti hormonal therapy\nPR\nIHC\nprotein\nanastrazole, letrozole, exemestane, fulvestrant, tamoxifen, goserelin, leuprolide\nAnti inflammatory agents\nPIK3CA\nNGS\nDNA tumor\naspirin\nTARGETED THERAPY CLINICAL TRIALS\nDrug class\nBiomarker\nMethod\nAnalyte\nInvestigational agents\nAkt inhibitors\nARID1A\nNGS\nDNA tumor\nAZD5363, MK-2206, ipataserib\nimmunomodulatory agents\nTMB\nNGS\nDNA tumor\navelumab, atezolizumab, durvalumab, ipilimumab, nivolumab, pembrolizumab\nPARP inhibitors\nNBN\nNGS\nDNA tumor\nBGB-290, BMN-673, olaparib, rucaparib, talazoparib\nAkt/mTor inhibitors\nPIK3CA\nNGS\nDNA tumor\nAZD5363, BYL719, MK-2206, ipataserib, everolimus, temsirolimus\nPATIENT: Alison Jones\nCASE NUMBER: 4751\nPHYSICIAN: Dr. Wanda Nguyen\n",
      "paragraphs": [
        "Clinical Trials Connector",
        "Final Report",
        "CHEMOTHERAPY CLINICAL TRIALS",
        "Drug class",
        "Biomarker |",
        "Method",
        "Analyte",
        "Investigational agents",
        "Anti hormonal therapy",
        "ER",
        "IHC",
        "protein",
        "anastrazole, letrozole, exemestane, fulvestrant, tamoxifen, goserelin, leuprolide",
        "Anti hormonal therapy",
        "PR",
        "IHC",
        "protein",
        "anastrazole, letrozole, exemestane, fulvestrant, tamoxifen, goserelin, leuprolide",
        "Anti inflammatory agents",
        "PIK3CA",
        "NGS",
        "DNA tumor",
        "aspirin",
        "TARGETED THERAPY CLINICAL TRIALS",
        "Drug class",
        "Biomarker",
        "Method",
        "Analyte",
        "Investigational agents",
        "Akt inhibitors",
        "ARID1A",
        "NGS",
        "DNA tumor",
        "AZD5363, MK-2206, ipataserib",
        "immunomodulatory agents",
        "TMB",
        "NGS",
        "DNA tumor",
        "avelumab, atezolizumab, durvalumab, ipilimumab, nivolumab, pembrolizumab",
        "PARP inhibitors",
        "NBN",
        "NGS",
        "DNA tumor",
        "BGB-290, BMN-673, olaparib, rucaparib, talazoparib",
        "Akt/mTor inhibitors",
        "PIK3CA",
        "NGS",
        "DNA tumor",
        "AZD5363, BYL719, MK-2206, ipataserib, everolimus, temsirolimus",
        "PATIENT: Alison Jones",
        "CASE NUMBER: 4751",
        "PHYSICIAN: Dr. Wanda Nguyen"
      ],
      "layout_metadata": {
        "block_types": [
          "heading-1",
          "header",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "paragraph",
          "footer",
          "footer",
          "footer"
        ],
        "has_tables": true
      }
    }
  ],
  "processing_timestamp": "2026-02-23T17:40:40.509315"
}